financetom
Business
financetom
/
Business
/
Northern Trust has never entertained discussions on sale, CEO says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Northern Trust has never entertained discussions on sale, CEO says
Jul 23, 2025 6:51 AM

July 23 (Reuters) - Northern Trust ( NTRS ) has not

entertained any discussions about a sale of the asset and wealth

manager, Chief Executive Mike O'Grady told analysts during a

post-earnings conference call on Wednesday.

"Contrary to recent speculation, during my tenure as CEO, we

have never entertained discussions regarding the sale of the

company with any financial institution, nor do we intend to,"

O'Grady said.

Last month, The Wall Street Journal reported that BNY had

approached its smaller rival, Northern Trust ( NTRS ), about a potential

merger.

Northern Trust ( NTRS ), which has a market cap of about $24.6

billion, later said it was fully committed to remaining

independent.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Shell Faces South Africa Top Court Hearing in Latest Round of Legal Battle With Environmental Activists
Market Chatter: Shell Faces South Africa Top Court Hearing in Latest Round of Legal Battle With Environmental Activists
Sep 16, 2025
08:12 AM EDT, 09/16/2025 (MT Newswires) -- Shell (SHEL) will have a legal case heard by South Africa's top court on Tuesday in the latest round of a legal battle pitting environmental activists against the energy giant, Bloomberg reported. The Constitutional Court in Johannesburg will hear two days of arguments from both sides over activist opposition to Shell and a...
Conavi Seeks FDA 510(k) Clearance for Next-Generation Novasight Intravascular Imaging System
Conavi Seeks FDA 510(k) Clearance for Next-Generation Novasight Intravascular Imaging System
Sep 16, 2025
08:13 AM EDT, 09/16/2025 (MT Newswires) -- Conavi Medical ( CNVIF ) Tuesday said it has submitted its next generation Novasight intravascular imaging system to the U.S. Food and Drug Administration (FDA) for 510(k) clearance for coronary applications. The 501(k) clearance is expected in the first half of next year with Conavi aiming for the U.S. commercial launch soon after....
Form 8.3 - Dowlais Group PLC
Form 8.3 - Dowlais Group PLC
Sep 16, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Form 8.3 - Greencore Group PLC
Form 8.3 - Greencore Group PLC
Sep 16, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved